1. Home
  2. VYGR vs BRR Comparison

VYGR vs BRR Comparison

Compare VYGR & BRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.80

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

BRR

Columbus Circle Capital Corp I Class A Ordinary Shares

HOLD

Current Price

$1.67

Market Cap

174.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
BRR
Founded
2013
2024
Country
United States
United States
Employees
N/A
5
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
203.6M
174.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
BRR
Price
$3.80
$1.67
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
613.0K
960.4K
Earning Date
05-08-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
$34.04
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.88
$1.31
52 Week High
$5.55
$10.51

Technical Indicators

Market Signals
Indicator
VYGR
BRR
Relative Strength Index (RSI) 55.96 49.72
Support Level $3.71 $1.48
Resistance Level $3.82 $2.13
Average True Range (ATR) 0.16 0.16
MACD 0.02 0.01
Stochastic Oscillator 73.68 73.40

Price Performance

Historical Comparison
VYGR
BRR

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About BRR Columbus Circle Capital Corp I Class A Ordinary Shares

ProCap Financial Inc is focused on Bitcoin-focused media products and Bitcoin holdings. The Company typically provides advertising and marketing services through weekly digital media placements, including audio and social media advertisements. The Company offers media products to help independent investors understand financial markets, current events, and technology advancements. These media products include social media accounts, email newsletters, and audio or video content. The Company also added strategies related to the use of AI and automation to support the development and delivery of financial products and services.

Share on Social Networks: